CONCERT PHARMACEUTICALS INC (CNCE) Stock Cash Flow
NASDAQ:CNCE - Nasdaq - US2060221056 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -126.31M | -80.05M | -74.80M | -78.20M | -56.00M | |||
| Depreciation Amortization | 1.27M | 1.48M | 1.60M | 1.70M | 1.20M | |||
| Change In Working Capital | 3.05M | 7.83M | -10.70M | 16.00M | 4.00M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | 500.00K | 100.00K | |||
| Other non cash items | 12.33M | 15.59M | 14.80M | 11.70M | 2.80M | |||
| OPERATING CASH FLOW | -109.66M | -55.15M | -69.00M | -48.80M | -48.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -281.00K | -255.00K | -200.00K | -700.00K | -2.90M | |||
| Other Investing Activity | -53.85M | 52.71M | 600.00K | 83.30M | 40.80M | |||
| INVESTING CASH FLOW | -54.13M | 52.46M | 300.00K | 82.60M | 37.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 152.74M | 64.56M | 70.90M | 1.50M | -200.00K | |||
| Other Financing Activity | N/A | 2.58M | 22.00M | N/A | N/A | |||
| FINANCING CASH FLOW | 155.32M | 67.13M | 92.90M | 1.50M | -200.00K | |||
| CHANGE IN CASH | -8.47M | 64.43M | 24.20M | 35.30M | -10.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -109.66M | -55.15M | -69.00M | -48.80M | -48.00M | |||
| Capital Expenditure | -281.00K | -255.00K | -200.00K | -700.00K | -2.90M | |||
| FREE CASH FLOW | -109.94M | -55.41M | -69.20M | -49.50M | -50.90M | |||
All data in USD